Bb Biotech Ag

Q2 2022 13F Notice

Signature - Title
Daniel Koller / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen
Holdings as of
June 30, 2022
Date filed
8/11/2022, 11:01 AM
Form type
13F-NT
Description
No holdings are reported in this report, and all US holdings are reported by other reporting manager(s). Top holdings included .
Previous filing
Q1 2019 - May 13, 2019
SEC
View on sec.gov

Bb Biotech Ag didn't report any stock holdings as of Q2 2022.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Daniel Koller / Ivo Betschart SIGNING AUTHORITY Kuesnacht, Switzerland 8/4/2022

Bellevue Group AG is reporting for Bb Biotech Ag:

Name Holdings Value Location File Number
Bellevue Group AG $4.81B Kuesnacht, Switzerland 028-17462